| Absence of p21WAF1 cooperates with c-myc in bypassing Ras-induced senescence and enhances oncogenic cooperation. | None |
| Pathways for activation of the ras-oncogene-encoded p21 protein. | None |
| COX-2, with a consequent increase in peroxides and DNA damage, contributes to the dominant oncogenicity of mutant K-ras. | None |
| Ras oncogene induces ST6gal1 via a RalGEF-mediated signal to its housekeeping promoter. | None |
| Evidence that the ras oncogene-encoded p21 protein induces oocyte maturation via activation of protein kinase C. | None |
| LTB4-BLT2-linked cascade plays a crucial mediatory role in the cell transformation induced by oncogenic Ha-Ras(V12), possibly acting downstream of Rac-cPLA2 | None |
| HIF-1alpha(785) may play an important role in tumor promotion mediated by the Ras oncogene, phorbol ester or tumor growth factors | None |
| Oncogenic Dbl, Cdc42, and p21-activated kinase form a ternary signaling intermediate through the minimum interactive domains. | None |
| An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. | None |
| comparison with human data show a pattern of gene expression indicative of KRAS2 mutation and oncogenic activity | None |
| comparison with mouse data show a pattern of gene expression indicative of KRAS2 mutation and oncogenic activity | None |
| importance of phospholipase D in the oncogenic ability of Ras | None |
| Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras. | None |
| Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation. | None |
| Transcription inhibition of oncogenic KRAS by a mutation-selective peptide nucleic acid conjugated to the PKKKRKV nuclear localization signal peptide. | None |
| Molecular dynamics structures of peptide nucleic acid x DNA hybrid in the wild-type and mutated alleles of Ki-ras proto-oncogene--stereochemical rationale for the low affinity of PNA in the presence of an AC mismatch. | None |
| It is reported report that ras oncogene, an established inhibitor of anoikis, triggers a significant upregulation of anti-apoptotic proteins cIAP2 and XIAP in intestinal epithelial cells. | None |
| found a strong (25- to 40-fold) synergistic stimulation of the gastrin promoter by the combination of oncogenic beta-catenin and K-ras overexpression | None |
| Detection of circulating cancer cells with K-ras oncogene using membrane array. | None |
| The KRAS oncogene: past, present, and future. | None |